ExploreWatchlistsPricing
  1. JP-listed companies
  2. OLYMPUS CORPORATION
  3. Financials
  4. Capital expenditures

OLYMPUS CORPORATION (7733)

Market cap
¥1.75T
P/E ratio
18.2x
Olympus manufactures medical endoscopes and therapeutic devices for hospitals and healthcare providers worldwide, specializing in gastrointestinal, surgical, and diagnostic equipment.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Mar 31, 2025-46,001-0.91%
Mar 31, 2024-46,425-2.41%
Mar 31, 2023-47,570+14.11%
Mar 31, 2022-41,688+7.83%
Mar 31, 2021-38,660+2.35%
Mar 31, 2020-37,774-19.79%
Mar 31, 2019-47,094-3.60%
Mar 31, 2018-48,855+12.20%
Mar 31, 2017-43,542-13.64%
Mar 31, 2016-50,422+40.24%
Mar 31, 2015-35,955

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat